Claudio Sini

749 total citations
28 papers, 440 citations indexed

About

Claudio Sini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Claudio Sini has authored 28 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Claudio Sini's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Claudio Sini is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Claudio Sini collaborates with scholars based in Italy, United States and United Kingdom. Claudio Sini's co-authors include Carlo Genova, Maria Giovanna Dal Bello, Erika Rijavec, Francesco Grossi, Giulia Barletta, Simona Coco, Angela Alama, Anna Truini, Francesco Boccardo and Giovanni Rossi and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Claudio Sini

25 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Sini Italy 15 235 227 163 128 48 28 440
Nicole Drezner United States 8 233 1.0× 218 1.0× 160 1.0× 73 0.6× 29 0.6× 13 430
Jun Koshio Japan 6 247 1.1× 125 0.6× 167 1.0× 87 0.7× 78 1.6× 11 464
Allison Tyler United States 10 194 0.8× 220 1.0× 149 0.9× 108 0.8× 52 1.1× 23 393
Rinat Galiulin United States 6 370 1.6× 388 1.7× 135 0.8× 110 0.9× 37 0.8× 7 556
Enrica Capelletto Italy 12 238 1.0× 265 1.2× 182 1.1× 76 0.6× 14 0.3× 31 444
Sushma Jonna United States 8 208 0.9× 203 0.9× 202 1.2× 180 1.4× 25 0.5× 14 452
V. Papadimitrakopoulou United States 13 313 1.3× 304 1.3× 223 1.4× 110 0.9× 29 0.6× 41 606
Ali Saber Netherlands 14 205 0.9× 170 0.7× 269 1.7× 148 1.2× 26 0.5× 34 506
Roy Elias United States 11 191 0.8× 141 0.6× 165 1.0× 62 0.5× 56 1.2× 40 411
Elena Poletto Italy 14 398 1.7× 183 0.8× 168 1.0× 189 1.5× 46 1.0× 34 585

Countries citing papers authored by Claudio Sini

Since Specialization
Citations

This map shows the geographic impact of Claudio Sini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Sini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Sini more than expected).

Fields of papers citing papers by Claudio Sini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Sini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Sini. The network helps show where Claudio Sini may publish in the future.

Co-authorship network of co-authors of Claudio Sini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Sini. A scholar is included among the top collaborators of Claudio Sini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Sini. Claudio Sini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avancini, Alice, Niccolò Giaj‐Levra, Gabriele Minuti, et al.. (2025). Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study. Lung Cancer. 203. 108531–108531.
2.
Bria, Emilio, José Luís Costa, Claudio Sini, et al.. (2024). 1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database. Annals of Oncology. 35. S818–S818. 1 indexed citations
3.
Putzu, Carlo, Giovanni Maria Fadda, Claudio Sini, et al.. (2024). Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy. Current Oncology. 31(9). 4955–4967. 4 indexed citations
4.
Russo, Anna, Claudio Sini, Diego Cortinovis, et al.. (2024). 1301P BRAF-mutant metastatic non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database. Annals of Oncology. 35. S828–S828.
5.
Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers. 12(5). 1125–1125. 48 indexed citations
6.
Coco, Simona, Simona Boccardo, Marco Mora, et al.. (2020). Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer. Clinical Breast Cancer. 21(3). 218–230.e6. 2 indexed citations
7.
Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Präzisionsmedizin bei NSCLC im Zeitalter der Immuntherapie: Neue Biomarker zur Selektion der am besten geeigneten Therapie oder des am besten geeigneten Patienten. 8(6). 300–317. 1 indexed citations
8.
Coco, Simona, Silvia Bonfiglio, Davide Cittaro, et al.. (2019). Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers. 11(4). 441–441. 3 indexed citations
9.
Genova, Carlo, Gemma Rossi, Aldo Pezzuto, et al.. (2019). P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial). Journal of Thoracic Oncology. 14(10). S829–S830. 2 indexed citations
10.
Rossi, Giovanni, Aldo Pezzuto, Claudio Sini, et al.. (2019). Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario. Critical Reviews in Oncology/Hematology. 142. 26–34. 47 indexed citations
11.
Coco, Simona, Angela Alama, Irene Vanni, et al.. (2017). Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. International Journal of Molecular Sciences. 18(5). 1035–1035. 37 indexed citations
12.
Grossi, Francesco, Erika Rijavec, Carlo Genova, et al.. (2016). Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy. British Journal of Cancer. 116(1). 36–43. 16 indexed citations
13.
Coco, Simona, Anna Truini, Angela Alama, et al.. (2014). Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Targeted Oncology. 10(3). 393–404. 35 indexed citations
14.
Coco, Simona, Anna Truini, Irene Vanni, et al.. (2014). Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine. Current Drug Targets. 16(1). 47–59. 38 indexed citations
15.
Truini, Anna, Simona Coco, Angela Alama, et al.. (2014). Role of microRNAs in malignant mesothelioma. Cellular and Molecular Life Sciences. 71(15). 2865–2878. 27 indexed citations
16.
Genova, Carlo, Erika Rijavec, Anna Truini, et al.. (2013). Pemetrexed for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 14(11). 1545–1558. 24 indexed citations
17.
Grossi, Francesco, Carlo Genova, Maria Giovanna Dal Bello, et al.. (2013). Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy. Lung Cancer. 81(2). 236–240. 20 indexed citations
18.
Puzone, Roberto, Sandra Salvi, Maria Giovanna Dal Bello, et al.. (2013). Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients. Molecular Cancer. 12(1). 97–97. 30 indexed citations
19.
Grossi, Francesco, Claudio Sini, Giulia Barletta, et al.. (2012). The relevance of stable disease (SD) as a surrogate end-point in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib (E) as the second/third line.. Journal of Clinical Oncology. 30(15_suppl). 7577–7577. 2 indexed citations
20.
Genova, Carlo, Erika Rijavec, Giulia Barletta, et al.. (2012). Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer. Expert Opinion on Biological Therapy. 12(7). 939–948. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Drezner Breakdown of academic impact, for papers by Jun Koshio Breakdown of academic impact, for papers by Allison Tyler Breakdown of academic impact, for papers by Rinat Galiulin Breakdown of academic impact, for papers by Enrica Capelletto Breakdown of academic impact, for papers by Sushma Jonna Breakdown of academic impact, for papers by V. Papadimitrakopoulou Breakdown of academic impact, for papers by Ali Saber Breakdown of academic impact, for papers by Roy Elias Breakdown of academic impact, for papers by Elena Poletto
Rankless by CCL
2026